You are being directed to ZacksTrade, a division of Zacks & Company and licensed broker-dealer. ZacksTrade and Zacks.com are separate but affiliated companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.

If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.

OK Cancel

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 08/22/2014

Company Name Symbol %Change
PLANAR SYSTE PLNR
5.21%
BITAUTO HOLD BITA
5.12%
POWERSECURE POWR
4.61%
CTPARTNERS E CTP
4.26%
STRATASYS LT SSYS
4.02%
Merck (MRK) Approaches New Downside Target of $40.53

Print Share

Dec 28, 2012 (SmarTrend(R) News Watch via COMTEX) -- Shares of Merck (NYSE:MRK) opened today below their pivot of $41.14 and have already reached the first level of support at $40.86. Investors may be interested in a cross of the next downside pivot targets of $40.53 and $39.92.

In the past 52 weeks, shares of Merck have traded between a low of $36.91 and a high of $48.00 and are now at $40.91, which is 11% above that low price. Over the past week, the 200-day moving average (MA) has remained constant while the 50-day MA has declined 0.6%.

There is potential upside of 21.2% for shares of Merck based on a current price of $40.91 and an average consensus analyst price target of $49.56. Merck shares should first meet resistance at the 200-day moving average (MA) of $41.99 and find additional resistance at the 50-day MA of $44.51.

SmarTrend is monitoring the recent change of momentum in Merck. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Merck in search of a potential trend change.

Write to Chip Brian at cbrian@mysmartrend.com

---------------------------------------------------------------------------------------------

SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup

Copyright, Comtex News Network, Inc. 2012

Free Stock Analysis From Zacks

Includes Zacks Long-Term Recommendation and Target Price

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.